BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives
A strong association between pancreatic cancer and <i>BRCA1</i> and <i>BRCA2</i> mutations is documented. Based on promising results of breast and ovarian cancers, several clinical trials with poly (ADP-ribose) polymerase inhibitors (PARPi) are ongoing for gastrointestinal (G...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/11/3346 |